{
    "clinical_study": {
        "@rank": "161623", 
        "arm_group": {
            "arm_group_label": "open label", 
            "arm_group_type": "Experimental", 
            "description": "Non Cadaveric human BellaDerm Acellular dermal tissue"
        }, 
        "brief_summary": {
            "textblock": "The purpose of this study is to Evaluate the efficacy and longevity of a Human-derived,\n      non-cadaveric, acellular dermal implant (BellaDerm) as a posterior spacer graft in the\n      correction of lower eyelid retraction, taking into consideration issues associated with the\n      use of acelular dermis such as contraction and potential regression of repairs."
        }, 
        "brief_title": "An Outcomes Assessment of the Utility of Belladerm Acellular Dermal Allograft in Ocular Lower Lid Retraction Repair", 
        "completion_date": {
            "#text": "January 2014", 
            "@type": "Actual"
        }, 
        "condition": "Lower Eyelid Retraction", 
        "detailed_description": {
            "textblock": "To Evaluate the efficacy and longevity of a Human-derived, non-cadaveric, acellular dermal\n      implant (BellaDerm) as a posterior spacer graft in the correction of lower eyelid\n      retraction, taking into consideration issues associated with the use of acelular dermis such\n      as contraction and potential regression of repairs."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Lower eyelid retraction, defined as inferior displacement of the lower eyelid margin\n             with inferior scleral show, may be asymptomatic\n\n          -  May have ocular irritation including foreign body sensation, burning, photophobia and\n             tearing.\n\n          -  May have aesthetically unsatisfactory eyelid appearance.\n\n        Exclusion Criteria:\n\n          -  Have a condition that would be contraindicated to surgery"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "95 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "12", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "May 6, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02133495", 
            "org_study_id": "KMBella1"
        }, 
        "intervention": {
            "arm_group_label": "open label", 
            "intervention_name": "Non Cadaveric Human Acellular Dermal Tissue", 
            "intervention_type": "Procedure", 
            "other_name": "Bella Derm"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "lower eyelid", 
            "retraction"
        ], 
        "lastchanged_date": "May 7, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Wayne", 
                    "country": "United States", 
                    "state": "Pennsylvania", 
                    "zip": "19087"
                }, 
                "name": "Morgenstern Center for Orbital and Facial Plastic Surgery"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "Use of Non-Cadaveric Human Acellular Dermal Tissue (BellaDerm\u00ae) in Lower Eyelid Retraction Repair", 
        "other_outcome": {
            "description": "Pre and post operative margin reflex distance 2 (MRD2) and inferior scleral show (ISS) where measured for each eyelid elevation and decrease in inferior scleral show.", 
            "measure": "Inferior scleral show", 
            "safety_issue": "No", 
            "time_frame": "1 year"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "January 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Pre and postoperative margin reflex distance 2 (MRD2) and inferior scleral show (ISS) was measured of each eyelid, and success was defined as a positive eyelid elevation and decrease in inferior scleral show. Long- term stability beyond 12 months was evaluated.", 
            "measure": "Pre and Post operative margin reflex distance 2 MRD 2", 
            "safety_issue": "No", 
            "time_frame": "1 year"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02133495"
        }, 
        "responsible_party": {
            "investigator_affiliation": "SGM Physician Research Consortium", 
            "investigator_full_name": "Kenneth Morgenstern, MD", 
            "investigator_title": "Kenneth Morgenstern, MD", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "SGM Physician Research Consortium", 
        "sponsors": {
            "collaborator": {
                "agency": "Musculoskeletal Transplant Foundation", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "SGM Physician Research Consortium", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2011", 
        "study_design": "Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}